GST Bill passage failed to cheer investors as the stock markets closed flat amid firm global markets. Sensex ended 16.86 points, or 0.06 per cent, higher at 27,714.37, while NSE Nifty ended 6.25 points, or 0.07 per cent up at 8,551.1.
Below are the 8 stocks that are in focus today
Natco Pharma: Stocks of the pharma company settled the day 3.85 per cent up at Rs 629.75 after it received final Abbreviated New Drug Application (ANDA) approval for generic versions of Tamilflu oral capsules (Roche’s trade name for Oseltamivir Phosphate), 30 mg, 45 mg and 75 mg.
Motherson Sumi Systems: Share price of the auto component maker ended the day 5.60 per cent up at Rs 347.70 after it decided to seek shareholders’ nod to raise over Rs 3,550 crore with an objective to meet long term goals.
Bata India: Share price of the company ended 4.44 per cent down at Rs 528.65 after the footwear major posted 44 per cent decline in standalone net profit at Rs 50.50 crore for the quarter ended June, 2016 as compared to Rs 90.19 crore in the corresponding quarter a year ago.
DHFL: Share price of the housing finance firm generated interest and closed 4.57 per cent up at Rs 234.40 as its maiden issue of non-convertible debentures was subscribed nearly 19-times on its first day on Wednesday with overall subscription of about Rs 19,000 crore.
Ramco Cements: Stocks of the company closed 16.13 per cent down at Rs 548.70 after it posted a 57 per cent growth in standalone net profit at Rs 155.93 crore for the quarter ended June 30, helped by better sales and cost optimisation measures.
Tribhovandas Bhimji Zaveri (TBZ): Stocks of jewellery firm ended 3.12 per cent down at Rs 68.40 after its first quarter results which saw 8.8 per cent decline in standalone net profit at Rs 2.47 crore for the quarter ended June 30 as against net profit of Rs 2.71 crore in the year-ago period.
Punj Lloyd Ltd: Stocks of the company closed 4.06 per cent up at Rs 20.50 after its arm Pt Engineering Limited has sold its entire stake in UK-based Simon Carves Engineering to Engineers and Constructors International Inc for $2 million.
Cadila Healthcare: Stocks of drug company ended 6.31 per cent up at Rs 368.90 despite it reporting 22.59 per cent dip in consolidated net profit to Rs 356.2 crore for the quarter ended June 30 as compared to net profit after taxes, minority interest and share of profit of associates and joint ventures of Rs 460.2 crore for the corresponding period of the previous fiscal.